On June 2, 2022, Astrid Waser will co-chair the first annual conference of ASCOLA Swiss Chapter regarding the Future of Swiss and European Merger Control which will take place in Zurich. The event will feature renowned speakers
Niederer Kraft Frey acted as legal counsel to the sales enablement platform for enterprise companies Pitcher on a transaction leading to a strategic growth investment from Crest Rock Partners. Founded in 2011 by Mert Yentür,
In October 2021, Stadler emerged as the winner of the tender held by Swiss Federal Railways (SBB), Thurbo and RegionAlps to award a framework agreement for the manufacture and delivery of up to 510 single-decker FLIRT multiple
Niederer Kraft Frey advised EPIC Suisse as issuer’s counsel in connection with its initial public offering and listing on SIX Swiss Exchange. The transaction represents the first traditional IPO on the Main Market of
MLL has advised Avobis Group on several different digitisation projects, including the legal structuring of the real estate matching plattform Property Captain which was recognized with the Best Swiss Web 2022 Award (gold in the category
Fema Retail acquired all shares in Ladenbau Schmidt from the Schmidt family last 13th of May. The purchase price was highly leveraged by UBS Switzerland and additionally financed by a seller’s loan. Ladenbau Schmidt,
Nater Dallafior‘s IP expert Mathis Berger has successfully represented PUMA SE in an important trademark litigation against FIFA (Fédération Internationale de Football Association). It is the first time that the Swiss Federal
The reinsurance German company Munich Re has acquired a stake in the Swiss company CertX becoming its largest single shareholder. Munich Re acquired the shares from the previous CertX majority shareholder, the University of Applied
Lenz & Staehelin associate Didier Nsanzineza has been elected Premier Secrétaire du Jeune Barreau de l’Ordre des avocats de Genève (Chairman of Geneva Young Bar Association) by the Bar’s general assembly
Engimmune Therapeutics, a Swiss biotech company based in Basel developing novel T-cell receptor (TCR)-based therapeutics, has closed a CHF 15.5m seed financing round. The round was led by the investors Pureos Bio-ventures and Novo
